# Cristina Ghenoiu

> Cristina Ghenoiu is a Series A investor at RA Capital Management backing Biotechnology and Medical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management)
- Location: Menlo Park, United States
- Total investments: 2
- Last investment: Jan 2026
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/cristina-ghenoiu-ph-d-2905b023/

Cristina Ghenoiu is a Principal at RA Capital Management, L.P. She attended Weill Cornell Graduate School of Medical Sciences.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Biopharma | 1 | 50% |
| Health Care | 1 | 50% |
| Life Science | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Juvena Therapeutics | Juvena Therapeutics is a venture-backed biopharma startup discovering novel protein-based therapeutics that promote tissue regeneration in the elderly and treat various age-related diseases. | $33.5M | Series B | Jan 12, 2026 |  |
| Capacity Bio | Capacity Bio is a therapeutics company that is focused on mitophagy. Capacity Bio is developing the most comprehensive and advanced mitophagy therapeutics and development platform for the purpose of restoring mitochondrial quality control in disease. | $35M | Series A | Mar 31, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together
- [Bison Ventures](https://shizune.co/investors/profile/bison-ventures) — VC Fund, 1 deal together
- [Eli Lilly](https://shizune.co/investors/profile/eli-lilly) — VC Fund, 1 deal together
- [Insight Partners](https://shizune.co/investors/profile/insight-partners) — VC Fund, 1 deal together
- [Jefferson Life Sciences](https://shizune.co/investors/profile/jefferson-life-sciences) — VC Fund, 1 deal together
- [Manta Ray Ventures](https://shizune.co/investors/profile/manta-ray-ventures) — VC Fund, 1 deal together

## About RA Capital Management

VC Fund · Boston, United States

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

5 contacts available at RA Capital Management.

| Name | Title | Profile |
| --- | --- | --- |
| Cristina Ghenoiu | Principal | https://shizune.co/investors/profile/cristina-ghenoiu |
| Ajay Yekkirala | VP, Head of Biology | https://shizune.co/investors/profile/ajay-yekkirala-9184 |
| Andrew Levin | Managing Director | https://shizune.co/investors/profile/andrew-levin |
| Barbara Herbst | Deputy Chief Compliance Officer | https://shizune.co/investors/profile/barbara-herbst |
| Dan Marks | Venture Senior Associate | https://shizune.co/investors/profile/dan-marks |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Cristina Ghenoiu invest in?

Cristina Ghenoiu invests primarily in Biotechnology, Medical and Biopharma startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Cristina Ghenoiu last invest?

The most recent investment recorded for Cristina Ghenoiu closed in Jan 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co